Sodium Alginate in Chocolate Milk, Satiety and Glycemic Control

NCT ID: NCT01877460

Last Updated: 2013-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares the effects of isovolumetric (325 ml) preloads of chocolate milk supplemented with sodium alginates at incremental doses on inter-meal glucose levels, appetite scores and food intake in healthy adult men. The findings of this study will illustrate whether the addition of sodium alginate to chocolate milk will improve the glycemic properties of chocolate milk and will potentiate its satiating characteristics. This study will also elucidate whether sodium alginates, incorporated into chocolate milk, will influence glycemia, appetite sensations and food intake in a dose-dependent manner. It is hypothesized that there will be a synergy between milk and sodium alginate beyond either alone. When combined with milk components, sodium alginate is expected to improve glycemia and induce satiety more than does either milk alone or alginate alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Appetite Regulation Glucose Metabolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sodium alginate-free chocolate milk

Sodium alginate-free chocolate milk (1% fat) (Beatrice Ltd., Toronto, Ontario)

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.

1.25% sodium alginate chocolate milk

Chocolate milk (Beatrice Ltd., Toronto, Ontario) with 1.25% sodium alginate

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.

2.5% sodium alginate chocolate milk

Chocolate milk (Beatrice Ltd., Toronto, Ontario) with 2.5% sodium alginate

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.

2.5% sodium alginate milk-free water-based solution

Water solution with 2.5% sodium alginate

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary intervention

All arms were given to all participants, in a randomized order, to be consumed within 10 min after 12-h overnight fasting.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy,
* non-smoking male subjects,
* aged 20-30 years with a body mass index between 20 and 24.9 kg/m2, were recruited.

Exclusion Criteria

* Breakfast skippers,
* smokers,
* dieters,
* individuals with lactose-intolerance or
* who are allergic to milk,
* individuals with gastrointestinal problems and
* individuals with diabetes or other metabolic diseases were excluded from the study.
Minimum Eligible Age

20 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

G. Harvey Anderson

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

G. Harvey Anderson, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Toronto

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Nutritional Sciences, FitzGerald Building

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

26942

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Soda and Milk Study
NCT02094768 COMPLETED NA
Almond Consumption and Glycemia
NCT03236116 COMPLETED NA